Good Clinical Practice (GCP)
Full course · Clinical Research Foundations
Free Lesson Preview
Enjoyed this preview?
This lesson is part of a complete GCP track — 2 courses, quizzes, a final exam, and a free verifiable credential. The optional $29 PDF certificate is recognized by 18+ trial sponsors.
Start learning for freeWho initiates, funds, and manages clinical trials, and how sponsors work with CROs to bring new treatments from laboratory to patient.
What you will learn5 objectives
By the end of this lesson, you will be able to:
Think of the sponsor as the architect and general contractor of a clinical trial. Just as a construction project needs someone to design the building, hire the workers, obtain the materials, and ensure the work meets code, a clinical trial needs someone to design the protocol, select the investigators, supply the investigational drug, and ensure the research meets regulatory standards.
The sponsor's core responsibilities include:
Designing the trial. The sponsor works with scientists, physicians, statisticians, and regulatory experts to create the protocol, the detailed document that describes exactly how the trial will be conducted.
Selecting and training investigators. The sponsor chooses which hospitals, clinics, and physicians will participate in the trial. They ensure these sites have the expertise, facilities, and patient populations needed for the research.
TableCore Sponsor Responsibilities
| Trial design | Create the protocol and all supporting documents | Defining patient eligibility criteria, treatment doses, and outcome measures |
| Investigator selection | Choose qualified sites to conduct the research | Evaluating whether a site has enough lung cancer patients |
| Product supply | Manufacture and distribute the investigational treatment | Shipping properly labeled study drug to each site |
| Oversight and monitoring | Verify that sites are following the protocol | Sending monitors to review patient records and drug accountability logs |
| Data management | Collect, clean, and analyze trial data | Building databases to capture information from all sites |
| Regulatory communication | Report to FDA and other agencies | Submitting serious adverse event reports within required timelines |
Not all sponsors look the same. Different types of organizations sponsor clinical trials for different reasons, and understanding these differences helps you understand the trial landscape.
Types of Clinical Trial Sponsors
Large pharmaceutical companies like those you see in television advertisements are the most common sponsors of clinical trials. They sponsor trials to develop new drugs for regulatory approval and eventual sale. These companies have large clinical development departments, extensive experience with regulations, and significant financial resources. Examples include companies developing new cancer treatments, cardiovascular drugs, or vaccines.
Biotech companies are typically smaller than traditional pharmaceutical companies and often focus on cutting-edge science like gene therapy, cell therapy, or novel biologics. Many biotech companies have only one or two products in development, making each trial critically important to their survival. They may have less internal infrastructure and rely more heavily on external partners.
Companies that develop medical devices such as pacemakers, surgical instruments, or diagnostic equipment also sponsor clinical trials. Device trials have some unique characteristics because the 'treatment' is a physical object rather than a medication, but the fundamental sponsor responsibilities remain the same.
Whether you are a research coordinator, study nurse, pharmacist, or data manager, the sponsor is your partner in conducting the trial. The sponsor provides the protocol you follow, the training you receive, the investigational product you dispense, and the oversight that helps catch problems before they become serious.
Understanding that the sponsor bears ultimate accountability helps explain why they are so particular about documentation, why monitors visit to verify your work, and why deviations from the protocol are taken so seriously. The sponsor's name will appear on the regulatory submission. If data are unreliable or participants are harmed, the sponsor faces consequences ranging from rejected applications to legal liability.
This accountability also means the sponsor has a stake in your success. A good sponsor provides clear guidance, responsive support, and adequate resources. When you have questions about the protocol, the sponsor's medical monitor can help. When you encounter unexpected situations, the sponsor's clinical team can advise. The relationship works best when it is a partnership, not just oversight.
Running a global clinical trial is enormously complex. A Phase 3 trial might involve hundreds of sites across dozens of countries, thousands of patients, millions of data points, and coordination with regulatory agencies worldwide. Most sponsors, even large pharmaceutical companies, cannot maintain all the specialized capabilities needed to run such trials entirely in-house.
This is where Contract Research Organizations, commonly called CROs, enter the picture.
A CRO is a company that provides clinical trial services to sponsors. CROs exist because of specialization and scale. Running clinical trials is their core business, and they have built expertise, systems, and global infrastructure specifically for this purpose.
CROs can provide virtually any service a sponsor needs to run a clinical trial. The scope of what a CRO does for any particular trial depends on the sponsor's needs, capabilities, and strategy.
Monitoring. Perhaps the most common CRO service is providing Clinical Research Associates (CRAs), also called monitors, who visit investigator sites to verify that trials are being conducted properly. CROs employ thousands of monitors worldwide who can be deployed to sites across the globe.
Data management. CROs build and maintain the electronic systems that capture trial data, manage the databases, perform quality checks, and prepare data for analysis.
Statistical analysis. Specialized statisticians at CROs analyze trial results and prepare the reports that accompany regulatory submissions.
TableCommon CRO Services
| Site monitoring | Clinical Research Associates who visit sites to verify proper trial conduct |
| Data management | Electronic data capture systems, database design, data cleaning |
| Biostatistics | Statistical analysis plans, interim analyses, final reports |
| Regulatory affairs | Submission preparation, agency interactions, approval tracking |
| Medical monitoring | Physician oversight, adverse event review, medical queries |
| Site selection | Feasibility assessment, site identification, startup support |
| Patient recruitment | Enrollment strategies, advertising, community outreach |
| Central laboratory | Sample processing, specialized testing, results reporting |
The relationship between sponsors and CROs takes different forms depending on the sponsor's strategy and the complexity of the trial.
Full-service outsourcing means the sponsor contracts with a single large CRO to manage nearly all aspects of trial execution. The CRO provides monitoring, data management, regulatory support, and other services as an integrated package. This approach suits sponsors who want a single point of accountability and do not maintain large internal clinical operations teams.
Functional service provider (FSP) model means the sponsor contracts with CROs to provide specific services or staff who work under the sponsor's direct management. For example, a sponsor might hire monitors through a CRO but manage them using the sponsor's own processes and oversight structure. This approach suits sponsors who want to maintain control while accessing specialized talent.
combine elements of both models. A sponsor might use one CRO for monitoring and data management while contracting with specialty CROs for laboratory services, imaging analysis, or patient recruitment.
Sometimes the same person who initiates a trial is also the physician who conducts it. This occurs most often in academic settings, where a researcher at a university medical center develops a promising idea and conducts a trial to test it without commercial sponsorship.
Consider a researcher at an academic medical center who has developed a novel rehabilitation protocol for stroke patients and wants to test whether it improves recovery compared to standard care. She writes a grant proposal to the NIH, receives funding, and designs a trial to be conducted at her institution and two partner hospitals.
In this scenario, she is a sponsor-investigator. She takes responsibility for initiating, managing, and financing the trial, which makes her a sponsor. She also directly conducts the trial at her institution, which makes her an investigator.
When an academic researcher serves as sponsor-investigator, she assumes responsibilities that would otherwise belong to a pharmaceutical company. She must ensure the trial has a quality management system. She must arrange for monitoring of all participating sites. She must collect and report safety information. She must maintain all the documentation that regulators expect.
These responsibilities can be challenging for academic researchers who have expertise in their scientific field but limited experience with regulatory requirements. Unlike a pharmaceutical company with entire departments devoted to clinical operations, regulatory affairs, and quality assurance, an academic researcher might have only a research coordinator and a few graduate students.
Academic institutions have developed support systems to help sponsor-investigators meet their obligations. Clinical and Translational Science Institutes, research compliance offices, and academic research organizations can provide guidance, training, and sometimes hands-on support for investigator-initiated trials. Some institutions have agreements with CROs to provide monitoring and other services for academic trials.
Case study · Clinical Research · intermediate · 10-15 minutes
Choosing the Right Approach
Dr. James Park at Riverside Medical Center has developed a promising new treatment for diabetic neuropathy. A pharmaceutical company, Meridian Health Sciences, has expressed interest in licensing the technology and conducting clinical trials to seek FDA approval.
Dr. Park faces a choice. He could license the technology to Meridian, which would then become the sponsor and manage all aspects of clinical development. Or he could retain the technology and seek grant funding to conduct his own investigator-initiated trial, becoming a sponsor-investigator himself.
Consider the implications:
If Meridian sponsors the trial, they bring resources, expertise, and infrastructure. They have clinical operations teams, established relationships with trial sites worldwide, experienced regulatory professionals, and deep pockets to fund large trials. However, Dr. Park loses control over how the research proceeds and may have limited influence over trial design decisions.
If Dr. Park remains sponsor-investigator, he retains scientific control and academic credit. He can design the trial exactly as he believes is scientifically appropriate. However, he must build infrastructure for all sponsor responsibilities, which may limit the size and scope of what he can accomplish with grant funding.
There is no universally correct answer. The best choice depends on Dr. Park's goals, resources, and risk tolerance. What matters is understanding what each choice entails and making an informed decision about who will bear sponsor responsibilities.
Understanding how sponsors relate to investigators helps explain the dynamics you will encounter in clinical research.
The sponsor selects and contracts with investigators, provides training on the protocol, supplies the investigational product, monitors the site's performance, and ultimately uses the data the site generates. This relationship involves significant oversight: sponsors have contractual authority to require corrective actions, can terminate sites that do not meet quality standards, and must approve many site-level decisions.
At the same time, the investigator retains independent responsibility for the medical care of trial participants. The sponsor cannot practice medicine at the site. The investigator exercises medical judgment about patient safety and treatment decisions. This creates a collaborative relationship where both parties have distinct responsibilities that must be coordinated.
When this relationship works well, it is a true partnership. The sponsor provides resources and support; the investigator provides expertise and access to patients. Communication flows freely in both directions. Problems are identified early and solved collaboratively. When it works poorly, the relationship becomes adversarial, with sponsors focused only on data collection and sites focused only on minimizing burden.
Question 1 of 5. Not yet answered.
Clinical trials do not happen spontaneously. Someone must decide to test a new treatment, design how the test will work, find the resources to pay for it, and take responsibility for conducting it properly. That someone is the sponsor.
Sponsors come in many forms: pharmaceutical giants, small biotechnology startups, academic institutions, government agencies, and disease-focused foundations. Regardless of their size or motivation, all sponsors share the fundamental responsibility for ensuring that trials protect participants and generate reliable data.
Because modern clinical trials are complex, sponsors often work with Contract Research Organizations that specialize in trial execution. These partnerships allow sponsors to access expertise and scale they could not maintain internally. But no matter how much work is delegated, the sponsor's accountability remains.
In academic settings, researchers who conduct their own trials become sponsor-investigators, taking on both sets of responsibilities. This requires understanding that regulatory expectations do not diminish for academic research; the standards are the same regardless of who sponsors the trial.
Sponsor: The individual, company, institution, or organization that takes responsibility for initiating, managing, and financing a clinical trial.
Contract Research Organization (CRO): A company contracted by the sponsor to perform one or more of the sponsor's trial-related duties and functions.
Sponsor-investigator: An individual who both initiates and conducts a clinical trial, assuming the responsibilities of both roles.
Investigator-initiated trial (IIT): A clinical trial initiated by an individual researcher rather than a commercial sponsor, typically conducted in academic settings.
A CRO that provides a comprehensive range of services, managing most aspects of trial execution as an integrated package.
Progress saves itself — finish reading and this lesson completes
Providing the investigational product. Whether it is a new drug, biologic, or device, the sponsor manufactures or obtains the product being tested and distributes it to the trial sites.
Overseeing the trial. The sponsor monitors the sites to ensure the protocol is being followed, the data are accurate, and the participants are being protected.
Collecting and analyzing data. The sponsor gathers information from all the trial sites, analyzes it, and draws conclusions about whether the treatment works.
Reporting to regulators. The sponsor communicates with regulatory authorities (such as the FDA in the United States, the EMA in Europe, or the PMDA in Japan), submitting safety reports during the trial and eventually the complete data package for approval decisions.
Universities, teaching hospitals, and research institutes sometimes sponsor their own trials, particularly when studying questions that commercial entities might not pursue. For example, a university might sponsor a trial comparing two already-approved treatments to determine which is more effective, a question that has value for patients but might not be commercially attractive.
The National Institutes of Health (NIH) and other government agencies sponsor significant research, particularly in areas like cancer, infectious disease, and rare diseases where commercial interest may be limited. Government-sponsored trials often focus on public health priorities and may study treatments that are already on the market.
Disease-focused foundations, such as those dedicated to cystic fibrosis, Alzheimer's disease, or rare cancers, sometimes sponsor or co-sponsor clinical trials. These organizations often step in when patient populations are too small to attract commercial sponsors.
Regulatory affairs. CROs help prepare and submit documents to regulatory agencies, navigate approval processes in different countries, and manage ongoing regulatory requirements.
Medical monitoring. Physicians employed by CROs review safety data, advise investigators on medical questions, and evaluate adverse events.
Site management. CROs identify and evaluate potential investigator sites, help with startup activities, and manage ongoing relationships with sites throughout the trial.
Patient recruitment. CROs develop strategies to find and enroll patients, working with sites and sometimes directly with patient communities.
Laboratory services. Central laboratories operated by or contracted through CROs process and analyze biological samples from trial participants.
Regardless of the model, one principle remains constant: the sponsor retains ultimate responsibility. A contract with a CRO does not transfer accountability to the CRO. If the CRO's monitors miss a serious problem at a site, the sponsor is responsible. If the CRO's data managers make errors, the sponsor is responsible. Sponsors must therefore actively oversee their CRO partners, which is why sponsor-CRO agreements include extensive provisions for oversight, auditing, and quality management.
The key lesson is that regulatory expectations do not decrease because a trial is academically sponsored. The same standards for participant protection and data integrity apply whether the sponsor is a multinational pharmaceutical company or a university professor. Sponsor-investigators must understand this and build appropriate infrastructure before launching their trials.
As you work in clinical research, you will interact with sponsors and their representatives regularly. Understanding their role, their responsibilities, and their accountability helps you understand why trials are structured as they are and why the expectations placed on sites exist. The sponsor is not just a distant entity that sends monitors and data queries. The sponsor is your partner in producing research that protects participants and advances medical knowledge.
Functional service provider (FSP): A model where a CRO provides specific services or staff who work under the sponsor's direct management rather than operating independently.
Clinical Research Associate (CRA): Also called a monitor, a professional who visits trial sites on behalf of the sponsor to verify proper trial conduct.
Medical monitor: A physician who provides medical oversight for a clinical trial, reviewing safety data and advising on medical questions.
